Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A Eskens

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Critical Reviews in Oncology/Hematology|May 9, 2000
Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: facing the challenge of a proper study designF A Eskens, J Verweij
The Oncologist|October 25, 2001
Matrix metalloproteinase inhibitors: current developments and future perspectivesR Hoekstra, F A Eskens, J Verweij
Cancer Treatment Reviews|September 28, 2000
Farnesyl transferase inhibitors: current developments and future perspectivesF A Eskens, G Stoter, J Verweij
Nederlands Tijdschrift Voor Geneeskunde|January 5, 2002
[Developments in chemotherapy; cytostatic agents with an increased specificity and other forms of administering cytotoxic antineoplastic agents]F A Eskens, M J de Jonge, J Verweij
Nederlands Tijdschrift Voor Geneeskunde|November 16, 1996
[Thromboembolic complications in central venous catheters]F A Eskens, C J Punt, C A Verhagen
The Netherlands Journal of Medicine|March 1, 1995
Septic shock caused by group G beta-haemolytic streptococci as presenting symptom of acute myeloid leukaemiaF A Eskens, P E Verweij, J F Meis, et al.
Anticancer Research|March 12, 1998
Pancreatic islet cell tumor producing vasoactive intestinal polypeptide and calcitoninF A Eskens, E J Roelofs, A R Hermus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Effect of food on the pharmacokinetics of oral MMI270B (CGS 27023A), a novel matrix metalloproteinase inhibitorF A Eskens, N C Levitt, A Sparreboom, et al.
Journal of Neuro-Oncology|December 3, 1999
Phase II study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent gliomaM J van den Bent, L Pronk, P A Sillevis Smitt, et al.
Neurology|July 27, 2001
Temozolomide chemotherapy in recurrent oligodendrogliomaM J van den Bent, F Keime-Guibert, A A Brandes, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Critical Reviews in Oncology/Hematology|May 9, 2000
Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: facing the challenge of a proper study designF A Eskens, J Verweij
The Oncologist|October 25, 2001
Matrix metalloproteinase inhibitors: current developments and future perspectivesR Hoekstra, F A Eskens, J Verweij
Cancer Treatment Reviews|September 28, 2000
Farnesyl transferase inhibitors: current developments and future perspectivesF A Eskens, G Stoter, J Verweij
Nederlands Tijdschrift Voor Geneeskunde|January 5, 2002
[Developments in chemotherapy; cytostatic agents with an increased specificity and other forms of administering cytotoxic antineoplastic agents]F A Eskens, M J de Jonge, J Verweij
Nederlands Tijdschrift Voor Geneeskunde|November 16, 1996
[Thromboembolic complications in central venous catheters]F A Eskens, C J Punt, C A Verhagen
The Netherlands Journal of Medicine|March 1, 1995
Septic shock caused by group G beta-haemolytic streptococci as presenting symptom of acute myeloid leukaemiaF A Eskens, P E Verweij, J F Meis, et al.
Anticancer Research|March 12, 1998
Pancreatic islet cell tumor producing vasoactive intestinal polypeptide and calcitoninF A Eskens, E J Roelofs, A R Hermus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Effect of food on the pharmacokinetics of oral MMI270B (CGS 27023A), a novel matrix metalloproteinase inhibitorF A Eskens, N C Levitt, A Sparreboom, et al.
Journal of Neuro-Oncology|December 3, 1999
Phase II study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent gliomaM J van den Bent, L Pronk, P A Sillevis Smitt, et al.
Neurology|July 27, 2001
Temozolomide chemotherapy in recurrent oligodendrogliomaM J van den Bent, F Keime-Guibert, A A Brandes, et al.
Pageof 2